BLICKENSTAFF KIM D 4
4 · TANDEM DIABETES CARE INC · Filed Nov 22, 2024
Insider Transaction Report
Form 4
BLICKENSTAFF KIM D
DirectorPRESIDENT AND CEO
Transactions
- Sale
Common Stock
2024-11-20$30.00/sh−10,000$300,000→ 195,190 total(indirect: See Footnote) - Sale
Common Stock
2024-11-21$31.38/sh−30,000$941,400→ 165,190 total(indirect: See Footnote)
Footnotes (3)
- [F1]The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $30.00 to $30.01
- [F2]The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
- [F3]The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $31.22 to $31.63.